HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST): Questions and Answers

treatment  trial  drug  screening  lung  tumor  genetic  gene  marker  mutation  ALK  EGFR  survival  ALCHEMIST 

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol

Preview   0 Users liked this content.
NCI

The ALCHEMIST Lung Cancer Trials

lung  NSCLC  ALK  EGFR  crizotinib  erlotinib 

A collection of material about the ALCHEMIST lung cancer trials that will examine tumor tissue from patients with certain types of early-stage, completely resected non-small cell lung cancer for gene mutations in the <i>EGFR</i> and <i>ALK</i> genes, and assign patients with these gene mutations to treatment trials testing post-surgical use of drugs targeted against these mutations.

Preview   0 Users liked this content.